P
Pajanivel Ranganadin
Researcher at Mahatma Gandhi Medical College & Research Institute
Publications - 8
Citations - 297
Pajanivel Ranganadin is an academic researcher from Mahatma Gandhi Medical College & Research Institute. The author has contributed to research in topics: Empyema & Decortication. The author has an hindex of 2, co-authored 6 publications receiving 31 citations.
Papers
More filters
Journal ArticleDOI
Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial.
Raches Ella,Siddarth Reddy,William C. Blackwelder,Varsha Potdar,Pragya D Yadav,Vamshi Sarangi,Vinay Kumar Aileni,Suman Kanungo,Sanjay K Rai,P. Prabhakar Reddy,Savita Verma,Chandramani Singh,Sagar Vivek Redkar,Satyajit Mohapatra,Anil Pandey,Pajanivel Ranganadin,Raghavendra Gumashta,Manish Multani,Shameem Mohammad,Parul Bhatt,Laxmi Kumari,Gajanan Sapkal,Nivedita Gupta,Priya Abraham,Samiran Panda,Sai Prasad,Balram Bhargava,Krishna Murthy Ella,Krishna Mohan Vadrevu +28 more
TL;DR: In this article, the authors reported the clinical efficacy against COVID-19 infection of BBV152, a whole virion inactivated SARS-CoV-2 vaccine formulated with a toll-like receptor 7/8 agonist molecule adsorbed to alum (Algel-IMDG) in Indian adults.
Posted ContentDOI
Efficacy, safety, and lot to lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): a double-blind, randomised, controlled phase 3 trial
Raches Ella Mbbs,Siddharth Reddy,William C. Blackwelder,Varsha Potdar,Pragya D Yadav,Vamshi Sarangi,Vinay Kumar Aileni,Suman Kanungo,Sanjay K Rai,P. Prabhakar Reddy,Savitha Verma,Chandramani Singh,Sagar Vivek Redkar,Satyajit Mohapatra,Anil Kumar Pandey,Pajanivel Ranganadin,Raghavendra Gumashta,Manish Multani,Shameem Mohammad,Parul Bhatt,Laxmi Kumari,Gajanan Sapkal,Nivedita Gupta,Priya Abraham,Samiran Panda,Sai Prasad,Balram Bhargava,Krishna Murthy Ella,Krishna Mohan Vadrevu +28 more
TL;DR: A double-blind, randomised, multicentre, phase 3 clinical trial in 25 Indian hospitals to evaluate the efficacy, safety, and immunological lot consistency of BBV152, a whole-virion inactivated SARS-CoV-2 vaccine formulated with a Toll-like receptor 7/8 agonist molecule adsorbed to alum as discussed by the authors.
Journal ArticleDOI
Neutralizing the free radicals could alleviate the disease severity following an infection by positive strand RNA viruses
Agieshkumar Balakrishna Pillai,Aashika Raagavi Jeanpierre,Vignesh Mariappan,Pajanivel Ranganadin,Rao S.R. +4 more
TL;DR: In this article , the authors discuss some of the common features in positive-strand RNA virus infections such as dengue and SARS-CoV-2 and suggest that anti-oxidant therapy could pave the way to develop therapeutic strategies in combating emerging and re-emerging RNA viruses.
Journal ArticleDOI
Early shedding of membrane-bounded ACE2 could be an indicator for disease severity in SARS-CoV-2
Vignesh Mariappan,Pajanivel Ranganadin,Lokesh Shanmugam,S.R. Rao,Agieshkumar Balakrishna Pillai +4 more
TL;DR: In this article , the levels of plasma ACE2 during the early phase of infection in COVID-19 patients were determined using ELISA at the time of admission and on day 7 post admission.
Journal ArticleDOI
Congenital bronchoesophageal fistula in an adult-report of a rare case.
TL;DR: Thoracoscopic approach can be considered in young, healthy adults where the adhesions are less and management is by surgical ligation of the fistula and repair.